-
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
02 Apr 2025 20:05 GMT
… Chief Executive Officer of Verrica Pharmaceuticals. “Gavin is a … of R&D at Stiefel Laboratories. He received his M …
YCANTH® is a proprietary drug-device combination product that … additional information. About Verrica Pharmaceuticals Inc.
Verrica is a …
-
Endor Labs: AI transparency vs ‘open-washing’
24 Feb 2025 23:44 GMT
… firm Endor Labs weighed in on these pressing topics.
Andrew Stiefel, Senior … Product Marketing Manager at Endor Labs, emphasised the … , operational risks, and openness.”
As Stiefel succinctly summarised: “Think about security …
-
Todd Stiefel, Party of One
19 Feb 2025 20:59 GMT
… for Prosparody.
His family owned Stiefel Laboratories, the world’s largest private … to sell the company to pharma and biotech giant GSK in 2009 … Stiefel Laboratories employees as well as major nonprofits.
In 2020, Stiefel Laboratories and Charles Stiefel …
-
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
Approval Date
Reference Listed Drug
Generic Drug Name
NDA Holder
ANDA Applicant
… ;05/2024
Soriatane
Acitretin
Stiefel Labs
Alembic
217774
08/05 …
Solu-Cortef
Hydrocortisone Sodium Succinate
Pharmacia and Upjohn
Cipla
214050
09 …
-
Rocket Lab USA, Inc. (NASDAQ:RKLB) Q3 2024 Earnings Call Transcript
13 Nov 2024 14:01 GMT
… Welcome everyone to the Rocket Lab Third Quarter 2024 Fiscal … Senior Communications Manager at Rocket Lab. You may begin.
Murielle … manufacturing and scaling to Rocket Lab. And Ken Possenriede also … line of Erik Rasmussen with Stiefel. Your line is open.
…
-
Alembic Pharmaceuticals receives final US FDA approval for Acitretin Capsules USP, 10 mg, 17.5 mg, 25 mg
08 Aug 2024 07:28 GMT
Mumbai: Alembic Pharmaceuticals Limited announced that … for its abbreviated new drug application (ANDA) Acitretin Capsules … to the reference listed drug product (RLD), Soriatane Capsules … , and 25 mg, of Stiefel Laboratories, Inc. Acitretin capsules are …
-
FDA approves Alembic’s psoriasis drug
07 Aug 2024 15:04 GMT
… the US Food and Drug Administration for psoriasis drug Acitretin in 10 … , and 25 mg strengths.
Alembic Pharmaceuticals Limited shares were trading at … generic is therapeutically equivalent to Stiefel Laboratories’ Soriatane capsules.
The estimated market …
-
Alembic Pharmaceuticals receives USFDA approval for Acitretin Capsules
07 Aug 2024 13:29 GMT
… Pharmaceuticals has received final approval from the US Food & Drug Administration … (USFDA) for its Abbreviated New Drug Application (ANDA) Acitretin Capsules USP … , and 25 mg, of Stiefel Laboratories, Inc. (Stiefel).
Acitretin capsules are indicated for …
-
Alembic Pharma gains after receiving US FDA nod for psoriasis treatment drug Acitretin
07 Aug 2024 08:29 GMT
… reference listed drug product (RLD), Soriatane Capsules of Stiefel Laboratories, Inc.
… from US FDA.
Alembic Pharmaceuticals is a vertically integrated research … and development pharmaceutical company. The company manufactures …
-
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
02 Jul 2024 17:00 GMT
… Dermatitis Drugs
Competitive Intelligence Analysis … Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech … including Basilea Pharmaceutica, Stiefel Laboratories, Regeneron, Leo Pharma, Japan Tobacco …
About
© 1995-2025